IDH2 and glioblastoma: Primary GBM has a poorer prognosis than secondary GBM, often exhibiting EGFR overexpression, 1p/10q LOH, and TERT promoter mutation and PTEN mutations, while secondary GBM is typically associated with IDH mutation, ATRX mutations, and TP53 mutations [3,8].